Biologic treatments in Behçet’s disease

Código QR

Biologic treatments in Behçet’s disease

Guardado en:

Detalles Bibliográficos
Autores principales:	Fatma Alibaz-Öner, Haner Direskeneli
Formato:	article
Lenguaje:	EN
Publicado:	AVES Yayincilik 2021
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/49bb77033fad4823911fc509aef22d4e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
por: Yusuf Karabulut
Publicado: (2021)

Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients
por: Cemal Gürbüz, et al.
Publicado: (2021)

Acute necrotizing pancreatitis as a manifestation of Behcet’s Disease: A case report and review of the literature
por: Geilan A. Mahmoud, et al.
Publicado: (2022)

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases
por: Cosimo Bruni, et al.
Publicado: (2021)

Features of systemic cytokine production in Behcet's disease associated with uveitis without ocular lesions
por: E. S. Sorozhkina, et al.
Publicado: (2021)

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls
por: Helene Broch Tenstad, et al.
Publicado: (2021)

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
por: Zhou DT, et al.
Publicado: (2015)

EFFECT OF HUMAN HERPES VIRUS REACTIVATION ON SYSTEMIC CYTOKINE PRODUCTION IN PATIENTS WITH BEHCET’S DISEASE AND UVEITIS
por: G. I. Krichevskaya, et al.
Publicado: (2021)

Ginger extract suppresses the activations of NF-κB and Wnt pathways and protects inflammatory arthritis
por: Burak Öz, et al.
Publicado: (2021)

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc
por: Eva Poveda, et al.
Publicado: (2010)

IMMUNOLOGY OF EYE DISEASES
por: Article Editorial
Publicado: (2015)

The use of preexposure treatments for HIV prophylaxis
por: Majid A, et al.
Publicado: (2012)

IMMUNOLOGY OF URINARY SYSTEM DISEASES
por: Article ed
Publicado: (2015)

IMMUNOLOGY OF CARDIOVASCULAR SYSTEM DISEASES
por: Article Editorial
Publicado: (2015)

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
por: Alana MacDonald, et al.
Publicado: (2021)

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
por: Pandey KK
Publicado: (2014)

Profile of darunavir in the management of treatment-experienced HIV patients
por: Cameron Wolfe, et al.
Publicado: (2009)

Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis
por: Sicong Li, et al.
Publicado: (2021)

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
por: Patel TS, et al.
Publicado: (2013)

The role of etravirine in the management of treatment-experienced pediatric patients with HIV
por: Osterholzer D
Publicado: (2013)

Long-term treatment of patients with HIV-1: the role of atazanavir
por: Miguel &Aacute;ngel Artacho, et al.
Publicado: (2010)

Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
por: Beatriz Larru Martinez, et al.
Publicado: (2010)

An update on the use of Atripla&reg; in the treatment of HIV in the United States
por: Michael A Horberg, et al.
Publicado: (2010)

Effect of once-daily FDC treatment era on initiation of cART
por: David M Mosen, et al.
Publicado: (2010)

Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS
por: Pullen SD, et al.
Publicado: (2014)

Sexual behaviors and associated factors among antiretroviral treatment attendees in Ethiopia
por: Demissie K, et al.
Publicado: (2015)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
por: Article Editorial
Publicado: (2015)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
por: Editorial article
Publicado: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
por: Editorial article
Publicado: (2014)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
por: Luiz Felipe Domingues Passero, et al.
Publicado: (2021)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
por: Seddon J, et al.
Publicado: (2011)

Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
por: Thore Lorenzen
Publicado: (2010)